Laser Treatment for Chemotherapy-Induced Peripheral Neuropathy Circle
Dr. Kate Perkins
30-40% of patients, globally, receiving chemotherapy will experience Chemotherapy Induced Peripheral Neuropathy (CIPN) at some point during or after treatment. OncoLaser utilizes the MLS Laser to heal and reduce symptoms of CIPN. With the synchronization of two wavelengths, MLS therapy is one of the most advanced laser therapy systems available to the market today. This Circle is designed to help practitioners track their everyday patients’ personal outcomes and correlate against specific settings with the MLS Laser system. Members will be able to contribute to, and benefit from, a growing repository of Laser Therapy real-world data, and will have the ability to collaborate with experts in the field. Circle members will own all data collected and will have the ability to monetize this real-world data they collect every day.
Observational
- Engage patients in long-term outcomes reporting, leading to improved adherence and results.
- Ownership of high-quality, real-world data with possibility of monetization and licensing.
- Collaborate with Laser experts to benchmark your results and receive mentorship.
- Get exposed to new, evidence-based techniques and treatment protocols for MLS Laser system.
- Quality of Life Questionnaire- Chemotherapy Induced Neuropathy 20 (QLQ-CIPN 20)
- Lower Extremity Functional Scale (LEFS)
Related Posts
Laser Treatment for Chemotherapy-Induced Peripheral Neuropathy Circle
30-40% of patients, globally, receiving chemotherapy will experience Chemotherapy Induced Peripheral Neuropathy (CIPN) at some point during or after treatment. OncoLaser utilizes the MLS Laser to heal and reduce symptoms of CIPN. With the synchronization of two wavelengths, MLS therapy is one of the most advanced laser therapy systems available to the market today. This Circle is designed to help practitioners track their everyday patients’ personal outcomes and correlate against specific settings with the MLS Laser system. Members will be able to contribute to, and benefit from, a growing repository of Laser Therapy real-world data, and will have the ability to collaborate with experts in the field. Circle members will own all data collected and will have the ability to monetize this real-world data they collect every day.
QLQ-CIPN 20; LEFS
- Engage patients in long-term outcomes reporting, leading to improved adherence and results.
- Ownership of high-quality, real-world data with possibility of monetization and licensing.
- Collaborate with Laser experts to benchmark your results and receive mentorship.
- Get exposed to new, evidence-based techniques and treatment protocols for MLS Laser system.
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
CIRCLE LIBRARY
CIRCLE NAME
Total Knee Arthroplasty Outcome-Based Performance Measure
SURVEYS
VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)
As specified by Provider
THIS CIRCLE IS FOR:
Provider Receiving CMS Reimbursement For TKAs
CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.
Other Providers Performing TKAs
Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.
WHY CIRCLES
If you have any questions, please contact us.